Opening the Blood-Brain Barrier and Improving the Efficacy of Temozolomide Treatments of Glioblastoma Using Pulsed, Focused Ultrasound with a Microbubble Contrast Agent

<div>Detection of GFAP expression by immunocytochemistry analysis (means ± SD, n = 3). GFAP expression in the tumor tissue in the test group was increased compared with that in control group. GFAP expression was localized to the cytoplasm.</div>

BioMed Research International

fig5

Figure 5

Figure 5: Opening the Blood-Brain Barrier and Improving the Efficacy of Temozolomide Treatments of Glioblastoma Using Pulsed, Focused Ultrasound with a Microbubble Contrast Agent 

Figure 5 | Opening the Blood-Brain Barrier and Improving the Efficacy of Temozolomide Treatments of Glioblastoma Using Pulsed, Focused Ultrasound with a Microbubble Contrast Agent 